J.SamuelsB
Witschi A, Reddy S, Stofer B, Lauterburg BH
Staying hydrated is crucial when taking GLP-1 medications, as they can significantly reduce thirst and slow digestion
doi: 10.1053/j.gastro.2007.03.054 [PubMed] [CrossRef] [Google Scholar] Mathiesen D.S., et al., The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A Review
The Therapeutic Goods Administration (TGA) granted approval in December 2024 for semaglutide 2.4 mg, sold under the brand name Wegovy, to be used as a complementary therapy for adults with both cardiovascular disease and high body mass index, to reduce the related risk of heart attack, stroke or death
Patients report faster treatment starts, clearer pricing, and simplified monthly billing compared to insurance-dependent alternatives